From liver to life: The overlooked impact of MASLD on digestive cancer outcomes.

e23070 Background: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is an increasing public health concern with the potential to increase the development of malignancy of the digestive tract and beyond. We aim to explore mortality trends of digestive cancer (DC) among MASLD patients. Methods: The CDC WONDER database was examined to extract age-adjusted mortality rates (AAMR) regarding DC among MASLD patients aged 25 years and older between 1999 and 2020. Data was stratified by age, gender, race, and U.S geographic regions. Results: 67616 deaths were documented from 1999 to 2020, with an overall AAPC of 2.8 (95% CI 1.99 to 3.62) and total AAMR of 13.6 (95%CI 13.5 to 13.7). Males showed higher mortality rates than females with an overall AAMR of 22.1 (95%CI 21.9 to 22.3). However, female gender showed higher AAPC with value of 3.6 (95%CI 2.88 to 4.32). Slight difference of AAPC between patients aged 55-64 and over 85 years as they showed the highest AAPC with value of 4.23 (95%CI 3.23 to 5.24) and 4.21 (95%CI 2.31 to 6.14) receptively. White race accounted for the highest AAPC followed by African American with 3.11 (95%CI 2.18 to 4.06) and 1.73 (95%CI 0.33 to 3.15) respectively. Conclusions: The highest AAPC was observed among Whites, older males, large central metropolitan residents and West residents. The observed disparities suggest the importance of improving outcomes for DC patients, particularly with MASLD. Keywords: Digestive cancer, MASLD, CDC WONDER, AAPC. Deaths and age-adjusted mortality rates (AAMRs) per 1,000,000 for digestive cancer among MASLD patients in the United States between 1999 and 2020. Variable Deaths (n) AAMR (95% CI) Overall 67,616 13.6 (13.5 to 13.7) Gender Female 22,396 8.3 (8.2 to 8.5) Male 30,529 14.7 (14.5 to 14.9) Race/Ethnicity Non- Hispanics 56,470 1.24 (1.23 to 1.25) Hispanics 10,552 2.6 (2.55 to 2.65) Geographic Region Northeast 10,571 11.3 (9.8 to 12.8) Midwest 12,154 11.1 (8.7 to 15.1) South 26,646 14.5 (8.8 to 19.7) West 18,245 16.9 (11.3 to 21.5)

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-05-28
DOI
https://doi.org/10.1200/jco.2025.43.16_suppl.e23070
Primary Topic
Diet and metabolism studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

From liver to life: The overlooked impact of MASLD on digestive cancer outcomes.

Mohammed Barawi, Husnain Ahmad, Pranjal Kumar Singh, Moeen Ikram et al.
Journal of Clinical Oncology
Diet and metabolism studies
article

From liver to life: The overlooked impact of MASLD on digestive cancer outcomes.

Mohammed Barawi, Husnain Ahmad, Pranjal Kumar Singh, Moeen Ikram, Mustafa Alsaadi, Muhammad Ismail, G Riffat, Mian Zahid Jan Kakakhel, Mohammad A. Zaied, Nana Sardarova
article en

Abstract

e23070 Background: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is an increasing public health concern with the potential to increase the development of malignancy of the digestive tract and beyond. We aim to explore mortality trends of digestive cancer (DC) among MASLD patients. Methods: The CDC WONDER database was examined to extract age-adjusted mortality rates (AAMR) regarding DC among MASLD patients aged 25 years and older between 1999 and 2020. Data was stratified by age, gender, race, and U.S geographic regions. Results: 67616 deaths were documented from 1999 to 2020, with an overall AAPC of 2.8 (95% CI 1.99 to 3.62) and total AAMR of 13.6 (95%CI 13.5 to 13.7). Males showed higher mortality rates than females with an overall AAMR of 22.1 (95%CI 21.9 to 22.3). However, female gender showed higher AAPC with value of 3.6 (95%CI 2.88 to 4.32). Slight difference of AAPC between patients aged 55-64 and over 85 years as they showed the highest AAPC with value of 4.23 (95%CI 3.23 to 5.24) and 4.21 (95%CI 2.31 to 6.14) receptively. White race accounted for the highest AAPC followed by African American with 3.11 (95%CI 2.18 to 4.06) and 1.73 (95%CI 0.33 to 3.15) respectively. Conclusions: The highest AAPC was observed among Whites, older males, large central metropolitan residents and West residents. The observed disparities suggest the importance of improving outcomes for DC patients, particularly with MASLD. Keywords: Digestive cancer, MASLD, CDC WONDER, AAPC. Deaths and age-adjusted mortality rates (AAMRs) per 1,000,000 for digestive cancer among MASLD patients in the United States between 1999 and 2020. Variable Deaths (n) AAMR (95% CI) Overall 67,616 13.6 (13.5 to 13.7) Gender Female 22,396 8.3 (8.2 to 8.5) Male 30,529 14.7 (14.5 to 14.9) Race/Ethnicity Non- Hispanics 56,470 1.24 (1.23 to 1.25) Hispanics 10,552 2.6 (2.55 to 2.65) Geographic Region Northeast 10,571 11.3 (9.8 to 12.8) Midwest 12,154 11.1 (8.7 to 15.1) South 26,646 14.5 (8.8 to 19.7) West 18,245 16.9 (11.3 to 21.5)

Journal of Clinical OncologyVol. 43(16_suppl)
University of Delhi (IN), Khyber Medical College (PK), Henry Ford Health System (US), Jordan University of Science and Technology (JO), Frontier Medical College (PK), Shalamar Hospital (PK), Henry Ford Hospital (US)
Openalex Percentile: Top 84%
Diet and metabolism studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.